(-)9-(3-Bromo-4-fluoro-phenyl)-1,1-dioxo-1,3,4,5,6,9-hexahydro-2H-1lambda*6*-furo[3,4-b]thiopyrano[2,3-e]pyridin-8-one

ID: ALA3392139

PubChem CID: 10201843

Max Phase: Preclinical

Molecular Formula: C16H13BrFNO4S

Molecular Weight: 414.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1OCC2=C1C(c1ccc(F)c(Br)c1)C1=C(CCCS1(=O)=O)N2

Standard InChI:  InChI=1S/C16H13BrFNO4S/c17-9-6-8(3-4-10(9)18)13-14-12(7-23-16(14)20)19-11-2-1-5-24(21,22)15(11)13/h3-4,6,13,19H,1-2,5,7H2

Standard InChI Key:  LLOBVWCCGRYZQL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    2.7655    0.4615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5142    0.7225    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3516    0.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1302    0.9990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1998   -0.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6208   -0.3227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8384   -0.6285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6430    1.1078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2884    1.8105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0445    0.5559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6531    2.3480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3921   -0.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8886    1.2667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2954    0.9987    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8031    3.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5884    3.4365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0654    2.0874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5398    1.9293    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1190    0.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2155    2.9004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2126   -0.8438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1782    3.7093    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    2.7383    4.2495    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.9669   -0.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4  1  1  0
  5  7  1  0
  6  1  2  0
  7  6  1  0
  8  3  1  0
  9  4  1  0
 10  8  1  0
 11  9  2  0
 12  5  1  0
 13  2  2  0
 14  2  2  0
 15 11  1  0
 16 20  1  0
 17  9  1  0
 18  8  2  0
 19  2  1  0
 20 17  2  0
 21  6  1  0
 22 15  1  0
 23 16  1  0
 24 21  1  0
 19 24  1  0
  3  5  2  0
 12 10  1  0
 15 16  2  0
M  END

Associated Targets(Human)

KCNJ11 Tclin Sulfonylurea receptors; K-ATP channels (596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.25Molecular Weight (Monoisotopic): 412.9733AlogP: 2.51#Rotatable Bonds: 1
Polar Surface Area: 72.47Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.29CX Basic pKa: CX LogP: 1.04CX LogD: 1.04
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: -0.72

References

1. Carroll WA, Agrios KA, Altenbach RJ, Buckner SA, Chen Y, Coghlan MJ, Daza AV, Drizin I, Gopalakrishnan M, Henry RF, Kort ME, Kym PR, Milicic I, Smith JC, Tang R, Turner SC, Whiteaker KL, Zhang H, Sullivan JP..  (2004)  Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.,  47  (12): [PMID:15163197] [10.1021/jm030357o]
2. Carroll WA, Agrios KA, Altenbach RJ, Buckner SA, Chen Y, Coghlan MJ, Daza AV, Drizin I, Gopalakrishnan M, Henry RF, Kort ME, Kym PR, Milicic I, Smith JC, Tang R, Turner SC, Whiteaker KL, Zhang H, Sullivan JP..  (2004)  Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.,  47  (12): [PMID:15163197] [10.1021/jm030357o]

Source